全文获取类型
收费全文 | 78460篇 |
免费 | 6380篇 |
国内免费 | 3986篇 |
专业分类
耳鼻咽喉 | 199篇 |
儿科学 | 1429篇 |
妇产科学 | 892篇 |
基础医学 | 13807篇 |
口腔科学 | 763篇 |
临床医学 | 6123篇 |
内科学 | 20154篇 |
皮肤病学 | 1094篇 |
神经病学 | 2678篇 |
特种医学 | 1354篇 |
外国民族医学 | 9篇 |
外科学 | 4126篇 |
综合类 | 11345篇 |
现状与发展 | 19篇 |
预防医学 | 7276篇 |
眼科学 | 490篇 |
药学 | 9342篇 |
22篇 | |
中国医学 | 3615篇 |
肿瘤学 | 4089篇 |
出版年
2023年 | 863篇 |
2022年 | 2020篇 |
2021年 | 2490篇 |
2020年 | 2350篇 |
2019年 | 2613篇 |
2018年 | 2503篇 |
2017年 | 2419篇 |
2016年 | 2877篇 |
2015年 | 3216篇 |
2014年 | 5161篇 |
2013年 | 5385篇 |
2012年 | 5219篇 |
2011年 | 5602篇 |
2010年 | 4506篇 |
2009年 | 4337篇 |
2008年 | 4210篇 |
2007年 | 4201篇 |
2006年 | 3795篇 |
2005年 | 3262篇 |
2004年 | 2680篇 |
2003年 | 2330篇 |
2002年 | 1922篇 |
2001年 | 1712篇 |
2000年 | 1378篇 |
1999年 | 1238篇 |
1998年 | 1113篇 |
1997年 | 935篇 |
1996年 | 733篇 |
1995年 | 789篇 |
1994年 | 671篇 |
1993年 | 506篇 |
1992年 | 478篇 |
1991年 | 373篇 |
1990年 | 340篇 |
1989年 | 296篇 |
1988年 | 251篇 |
1987年 | 216篇 |
1986年 | 184篇 |
1985年 | 454篇 |
1984年 | 464篇 |
1983年 | 376篇 |
1982年 | 382篇 |
1981年 | 321篇 |
1980年 | 295篇 |
1979年 | 264篇 |
1978年 | 210篇 |
1977年 | 163篇 |
1976年 | 179篇 |
1975年 | 154篇 |
1974年 | 131篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
巢式PCR检测先天性心脏病心脏石蜡标本中B19病毒的感染 总被引:2,自引:0,他引:2
目的:探讨微小病毒B19与先天性心脏病(CHD)的相关性及可能致畸机理。方法:采用病例对照研究,病例组为29例CHD尸解心脏组织,对照组为30例同期非先天性畸形尸解心脏组织,应用巢式PCR扩增B19-DNA,单纯疱疹病毒(HSV),兔弓形虫(TOX),巨细胞病毒(CMV),结果:29例CHDB19-DNA5例阳性,全瓿对照组为均阴性(P=0.0237),HSV,TOX两组中均阴性,CMV在两组中均 相似文献
102.
硒和/或维生素E预防大鼠内皮细胞损伤的实验研究 总被引:15,自引:1,他引:14
用含硒(Se0.5mg/kg)和/或维生素E(VE0.6g/kg)的高脂饲料喂养成年雄性Wistar大鼠12周。结果:高脂对照组大鼠血浆前列腺素Flα(6-酮-PGF1α)水平下降,而血清脂质过氧化物(LPO)、血浆血栓素(TXB2)及内皮素(ET)水平上升;补Se、VE及Se+VE可明显降低大鼠血清LPO、血浆TXB2、ET及TXB2/6-酮-PGF1α比值。同时,除了明显提高血浆谷胱甘肽过氧化物酶(GSH-Px)活力外,血浆6-酮-PGF1α浓度明显升高。实验提示,Se和/或VE有调节花生四烯酸代谢及保护内皮细胞的作用。 相似文献
103.
对29例慢性乙型肝炎伴肝胆结石患者.采用Elisa和斑点杂交技术检测外周静脉血、胆管胆汁和门静脉血中乙型肝炎两对半及HBV-DNA.并比较HkAg含量.结果,外周静脉血、胆汁和门静脉血中HBsAg浓度分别为;2244.73±59722ng/ml、1181.65±370.91ng/ml、2013.62±483.47ng/ml;HBV-DNA阳性检出率分别为62.07%(18例),72.41%(21例)及68.97%(20例).提示肝细胞内复制的HHV在进入血循环的同时,部分随胆汁的分泌排入肠道,并可能通过受损肠粘膜进入门静脉再回到肝脏,造成HBV对肝脏的重复感染。 相似文献
104.
Purpose. To determine whether the non-toxic pentameric B subunit of Cholera toxin (CTB) binding to ganglioside GM1 on both the lipid vesicles and epithelial cells may provide a means to target lipid vesicles to mucosal cells expressing surface GM1.
Methods. Sonicated lipid vesicles containing ganglioside GM1 were prepared. Inter-vesicle cross-linking due to pentameric CTB binding to these GM1 vesicles was determined with a sub-micron particle analyzer. Association of CTB to GM1 vesicles was analyzed with continuous sucrose gradient centrifugation. CTB-mediated binding of GM1 vesicles to human mucosal epithelial cells (Caco-2 and HT-29), mucous membranes of mouse trachea, and nasal tissues were detected with fluorescent labeled vesicles.
Results. An increase in lipid particle size due to binding of CTB to lipid vesicles and inter-vesicles cross-linking was detected. At a 30-to-1 mole ratio of membrane-bound GMl-to-CTB, optimum increase in GM1 vesicle aggregation, was detected. Under such conditions, all the added CTB molecules were associated with GM1 vesicles. Time course analysis showed that inter-vesicles cross linking by CTB was detectable within 10 min. and reached a maximum value at 60 min. CTB associated GM1-vesicles bind to mucosal epithelial cells HT-29 and Caco-2 with similar affinity [Kd = 7.8 × 10–4 M lipid (Caco-2) and 7.6 × 10–4 M lipid (HT-29)]. GM1 mediated binding specificity was demonstrated by blocking with anti-GMl antibody and the insignificant degree of CTB-associated GM1 vesicle binding to GM1 deficient C6 cells.
Conclusions. The CTB-mediated GM1 binding to multiple membrane surfaces provides selective localization of GM1 vesicles to GM1 expressing mucosal cells and tissues. The strategy may be useful in localizing drugs and proteins to gut and respiratory tract mucosa. 相似文献
105.
Hiroki Hamanaka Nobuaki Maeda Masaharu Noda 《The European journal of neuroscience》1997,9(11):2297-2308
Protein tyrosine phosphatase ζ (PTPζRPTPβ) is a proteoglycan-type receptor-like protein tyrosine phosphatase specifically expressed in the brain. In addition to the transmembrane form (PTPζ-A), the extracellular splice variant (PTPζ-S) occurs as a major soluble chondroitin sulphate proteoglycan in the brain. We prepared antibodies which specifically recognize PTPζ-A and -S, and analysed the carbohydrate structures on the two PTPζ isoforms in the developing chick brain. lmmunoprecipitation experiments using these antibodies revealed that almost all of the keratan sulphate recognized by a monoclonal antibody (5D4) was exclusively bound to PTPζ-A and PTPζ-S. Addition of keratan sulphate to these proteoglycans markedly increased from embryonic day (E) 11, in contrast to the addition of LeX and HNK-1 carbohydrates, which gradually increased during development in accordance with expression of the core proteins, suggesting that keratan sulphate modification plays some specific roles. Moreover, at the early embryonic stage keratan sulphate was observed only in several restricted regions, especially at boundary regions such as the roof plate of the tectum, the zona limitans intrathalamica in the diencephalon, and the mesencephalon-metencephalon boundary. At the mesencephalon-metencephalon boundary, keratan sulphate modification of PTPζ isoforms was specifically observed from E3 to E6 on a ring of cells encircling the neural tube and their radially oriented processes, which were identified as radial glial fibres. This expression pattern of keratan sulphate spatiotemporally corresponded well to the formation of the fovea isthmi, a groove separating the mesencephalon from the metencephalon. These results suggest that carbohydrates including keratan sulphate on PTPζ isoforms play important roles in brain development by modulating the cell-cell and/or cell-substrate interactions mediated by these molecules. 相似文献
106.
Mice homozygous for the lpr mutation have B and T cell defects and develop autoantibodies, suggesting that lpr plays a role in their genesis. The lpr defect has been identified as a mutation in the apoptosis-associated Fas receptor (FasR) gene. To begin to define the role of FasR in B cells, we have surveyed FasR expression on B-lineage cells from early progenitors in the bone marrow through their maturation in the periphery. Contrary to some reports, we found that FasR is expressed on B cells at all stages of their development and is highest on germinal center B cells. FasR is not expressed on lpr/lpr-derived cells. These data are consistent with the idea that lpr/lpr mice have an intrinsic B cell defect that may be manifested in developing as well as peripheral B cells. An unexpected finding is that B-1 (CD5) B cells do not constitutively express FasR: FasR becomes detectable on B-1 B cells only after activation. 相似文献
107.
Abstract: A prospective, randomized study was conducted to evaluate the role of vitamin B12 and folinic acid supplementation in preventing zidovudine (ZDV)-induced bone marrow suppression. Seventy-five human immunodeficiency virus (HIV)-infected patients with CD4 + cell counts < 500/mm3 were randomized to receive either ZDV (500 mg daily) alone (group I, n = 38) or in combination with folinic acid (15 mg daily) and intramascular vitamin B12 (1000 μg monthly) (group II, n = 37). Finally, 15 patients were excluded from the study (noncompliance 14, death 1); thus, 60 patients (31 in group I and 29 in group II) were eligible for analysis. No significant differences between groups were found at enrollment. During the study, vitamin B12 and folate levels were significantly higher in group II patients; however, no differences in hemoglobin, hematocrit, mean corpuscular volume, and white-cell, neutrophil and platelet counts were observed between groups at 3, 6, 9 and 12 months. Severe hematologic toxicity (neutrophil count < 1000/mm3 and/or hemoglobin < 8 g/dl) occurred in 4 patients assigned to group I and 7 assigned to group II. There was no correlation between vitamin B12 or folate levels and development of myelosuppression. Vitamin B12 and folinic acid supplementation of ZDV therapy does not seem useful in preventing or reducing ZDV-induced myelotoxicity in the overall treated population, although a beneficial effect in certain subgroups of patients cannot be excluded. 相似文献
108.
血清Ⅲ型原胶原含量与肝纤维化的关系(附102例肝活检分析) 总被引:1,自引:0,他引:1
为进一步研究血清Ⅲ型原胶原(PCⅢ)含量与肝纤维化的关系,对肝炎患者血清PCⅢ含量与肝炎组织学变化进行对比分析.方法:用RIA法测定616例急、慢性肝炎及肝硬化患者的血清PCⅢ含量,其中102例同时做肝活检,按照Knodell肝组织炎症活动性指数标准记分.结果:急、慢性肝炎及肝硬化患者血清PCⅢ含量明显高于正常人,差异有显著性(P<o.05~0.01).其升高的血清PCⅢ含量与肝细胞坏死范围及门管区炎症程度无相关性(r=0.494,P>0.05),而与肝纤维化程度呈正相关(r=0.668,P<0.01).结论:血清PCⅢ测定是判断慢性肝炎及肝硬化时肝纤维化程度的有用指标. 相似文献
109.
HBV-M定量检测与HBV-DNA含量水平关系的初步探讨 总被引:2,自引:0,他引:2
目的 研究乙型肝炎病毒标志物定量检测结果与其HBV-DNA含量的临床关系。方法 采用时间分辨免疫定量和荧光定量-PCR技术,对HBV-DNA和HBV-DNA含量进行检测。结果 在HBsAg/HBeAg/HBcAb,HBsAg/HBcAb/HBcAb,HBeAg/IC及单纯HBcAb阳性的四个组别中,HBV-DNA阳性率分别是97.17%、30.56%、100%和25%;在HBsAg,HBeAg,HBeAb,HBcAb定量检测高,低值两组HBV-DNA含量对比中,HBV-DNA阳性率分别为76.92%、58.14%;100%、97.26%;20.00%、11.42%;64.62%、27.63%。结论 HBV-DNV比HBV-M更能及时准确反映乙型肝炎病毒感染者的病程情况。 相似文献
110.
LightCycler实时监测PCR定量分析血清HBV DNA 总被引:2,自引:0,他引:2
目的 检验LightCycler实时监测PCR(real-time detection PCR,RTD-PCR)对血清中HBV DNA定量检测的灵敏性和可重复性,探讨HBV血清标志物与HBV DNA定量的关系。方法 HBV定量按深圳匹基公司乙肝PCR荧光检测试剂盒使用说明,对乙肝标志物已明确的773例血清中HBV DNA定量结果进行统计分析。结果 实时监测PCR对血清中HBV DNA定量检测的灵敏性高,可检测低至1000拷贝/ml血清;可重复性好,批间误差<20%;各种标志物类型的血清HBV DNA含量分布情况表明,HBV血清标志物中HBeAg与HBV DNA含量有明显的关系,一般HBeAg阳性血清HBV DNA含量较高,但也有相当一部分例外。结论 LightCycler实时监测PCR对血清中HBV DNA定量检测灵敏性高可重复性好;仅根据HBV血清标志物往往不能确定乙肝患者HBV DNA复制水平的高低,HBV DNA定量检测具有十分重要的临床意义。 相似文献